163 related articles for article (PubMed ID: 3004426)
1. The receptor binding properties of the 20K variant of human growth hormone explain its discrepant insulin-like and growth promoting activities.
Smal J; Closset J; Hennen G; De Meyts P
Biochem Biophys Res Commun; 1986 Jan; 134(1):159-65. PubMed ID: 3004426
[TBL] [Abstract][Full Text] [Related]
2. [22K and 20K growth hormone: correlation of receptor binding and the biological effect on rat adipocytes].
Smal J; Closset J; Hennen G; De Meyts P
Reprod Nutr Dev (1980); 1987; 27(2B):521-2. PubMed ID: 3306847
[TBL] [Abstract][Full Text] [Related]
3. Receptor binding properties and insulin-like effects of human growth hormone and its 20 kDa-variant in rat adipocytes.
Smal J; Closset J; Hennen G; De Meyts P
J Biol Chem; 1987 Aug; 262(23):11071-9. PubMed ID: 3301849
[TBL] [Abstract][Full Text] [Related]
4. Biological activities of synthesized 20K and 22K hGH in Nb2 bioassay and IM-9 radioreceptor assay.
Ohmae Y; Yano H; Umezawa S; Tanaka T; Hibi I; Miyamoto C; Furuichi Y
Endocrinol Jpn; 1989 Feb; 36(1):9-13. PubMed ID: 2731487
[TBL] [Abstract][Full Text] [Related]
5. 20K is bound with high affinity by one rat and one of two rabbit growth hormone receptors.
Hughes JP; Tokuhiro E; Simpson JS; Friesen HG
Endocrinology; 1983 Nov; 113(5):1904-6. PubMed ID: 6313333
[TBL] [Abstract][Full Text] [Related]
6. Cellular activities of 20K- and 22K-hGH do not necessarily correlate with their binding affinities for rat GH receptor.
Ikeda M; Matsumoto K; Uchida H; Naito N; Tsunekawa B; Wada M; Honjo M
Horm Res; 2000; 54(3):136-42. PubMed ID: 11357007
[TBL] [Abstract][Full Text] [Related]
7. The acute effects of growth hormone on amino acid transport and protein synthesis are due to its insulin-like action.
Cameron CM; Kostyo JL; Adamafio NA; Brostedt P; Roos P; Skottner A; Forsman A; Fryklund L; Skoog B
Endocrinology; 1988 Feb; 122(2):471-4. PubMed ID: 3276499
[TBL] [Abstract][Full Text] [Related]
8. Large-scale preparation and in vitro characterization of biologically active human placental (20 and 22K) and pituitary (20K) growth hormones: placental growth hormones have no lactogenic activity in humans.
Solomon G; Reicher S; Gussakovsky EE; Jomain JB; Gertler A
Growth Horm IGF Res; 2006; 16(5-6):297-307. PubMed ID: 17010651
[TBL] [Abstract][Full Text] [Related]
9. The 20,000 Da variant of human growth hormone does not bind to growth hormone receptors in human liver.
McCarter J; Shaw MA; Winer LA; Baumann G
Mol Cell Endocrinol; 1990 Oct; 73(1):11-4. PubMed ID: 2292336
[TBL] [Abstract][Full Text] [Related]
10. Binding characteristics of a biologically active variant of human growth hormone (20K) to growth hormone and lactogen receptors.
Sigel MB; Thorpe NA; Kobrin MS; Lewis UJ; Vanderlaan WP
Endocrinology; 1981 Apr; 108(4):1600-3. PubMed ID: 6258910
[TBL] [Abstract][Full Text] [Related]
11. Diabetogenic activity of 20 kDa human growth hormone (20K-hGH) and 22K-hGH in rats.
Takahashi S; Shiga Y; Satozawa N; Hayakawa M
Growth Horm IGF Res; 2001 Apr; 11(2):110-6. PubMed ID: 11472077
[TBL] [Abstract][Full Text] [Related]
12. The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the effect on the human prolactin receptor.
Tsunekawa B; Wada M; Ikeda M; Uchida H; Naito N; Honjo M
Endocrinology; 1999 Sep; 140(9):3909-18. PubMed ID: 10465259
[TBL] [Abstract][Full Text] [Related]
13. 20 kDa human growth hormone (20K hGH) stimulates insulin-like growth factor-I (IGF-I) gene expression at lower concentrations than 22K hGH in hGH receptor-expressing Ba/F3 cells.
Yoshizato H; Tanaka M; Fujikawa T; Higashimoto Y; Shimizu A; Nakashima K
Endocr J; 2000 Mar; 47 Suppl():S37-40. PubMed ID: 10890180
[TBL] [Abstract][Full Text] [Related]
14. Pituitary and recombinant deoxyribonucleic acid-derived human growth hormones alter glucose metabolism in 3T3 adipocytes.
Schwartz J; Foster CM
J Clin Endocrinol Metab; 1986 Apr; 62(4):791-4. PubMed ID: 3005358
[TBL] [Abstract][Full Text] [Related]
15. Exogenous 20K growth hormone (GH) suppresses endogenous 22K GH secretion in normal men.
Hashimoto Y; Kamioka T; Hosaka M; Mabuchi K; Mizuchi A; Shimazaki Y; Tsunoo M; Tanaka T
J Clin Endocrinol Metab; 2000 Feb; 85(2):601-6. PubMed ID: 10690862
[TBL] [Abstract][Full Text] [Related]
16. Evidence that the N-terminus of human growth hormone is involved in expression of its growth promoting, diabetogenic, and insulin-like activities.
Towns R; Kostyo JL; Vogel T; Sakal E; Tchelet A; Maher R; Gertler A
Endocrinology; 1992 Mar; 130(3):1225-30. PubMed ID: 1537288
[TBL] [Abstract][Full Text] [Related]
17. The 20kDa and 22kDa forms of human growth hormone (hGH) exhibit different intracellular signalling profiles and properties.
Yao-Xia L; Jing-Yan C; Xia-Lian T; Ping C; Min Z
Gen Comp Endocrinol; 2017 Jul; 248():49-54. PubMed ID: 28427901
[TBL] [Abstract][Full Text] [Related]
18. Turnover of growth hormone receptors in rat adipocytes.
Gorin E; Goodman HM
Endocrinology; 1985 May; 116(5):1796-805. PubMed ID: 2985362
[TBL] [Abstract][Full Text] [Related]
19. Binding of a variant of human growth hormone to liver plasma membranes.
Wohnlich L; Moore WV
Horm Metab Res; 1982 Mar; 14(3):138-41. PubMed ID: 6279479
[TBL] [Abstract][Full Text] [Related]
20. Recombinant deoxyribonucleic acid-derived 22K- and 20K-human growth hormone generate equivalent diabetogenic effects during chronic infusion in dogs.
Ader M; Agajanian T; Finegood DT; Bergman RN
Endocrinology; 1987 Feb; 120(2):725-31. PubMed ID: 3542508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
